The Efficacy of 308nm Excimer Laser in White Striae

This study has been completed.
Sponsor:
Information provided by:
Shahid Beheshti Medical University
ClinicalTrials.gov Identifier:
NCT00361361
First received: August 7, 2006
Last updated: February 19, 2008
Last verified: November 2006
  Purpose

The purpose of this study is to determine whether 308nm Excimer Laser therapy are effective in the color correction of white striae.


Condition Intervention Phase
White Striae
Excimer Laser
Device: Excimer Laser Therapy
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Efficacy of 308nm Excimer Laser in White Striae

Further study details as provided by Shahid Beheshti Medical University:

Primary Outcome Measures:
  • Clinical darkening of striaes

Secondary Outcome Measures:
  • Colorimetric assessment

Estimated Enrollment: 10
Study Start Date: July 2006
Study Completion Date: October 2006
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Excimer Laser Therapy
    excimer laser is a UV 308nm laser. repeated sessions (10 sessions) needed. once per week.
Detailed Description:

The use of excimer laser in modified program in white striae during a few months.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • White Striae

Exclusion Criteria:

  • Red Striae
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00361361

Locations
Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University
Tehran, Iran, Islamic Republic of, 19899
Sponsors and Collaborators
Shahid Beheshti Medical University
Investigators
Study Director: Nima Ostovari, M.D. Shahid Beheshti Medical University
Study Chair: Parviz Toossi, MD skin research center of shaheed-beheshti medical university
  More Information

No publications provided

Responsible Party: Dr.Nima Ostovari
ClinicalTrials.gov Identifier: NCT00361361     History of Changes
Other Study ID Numbers: src-ost-1360
Study First Received: August 7, 2006
Last Updated: February 19, 2008
Health Authority: Iran: Ministry of Health

Additional relevant MeSH terms:
Striae Distensae
Skin Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on July 22, 2014